CC
AMGN icon

Cypress Capital’s Amgen AMGN Stock Holding History

Cypress Capital’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.94M Sell
8,112
-251
-3% -$85.9K 0.79% 25
2026
Q1 		$2.94M Sell
8,363
-97
-1% -$34.6K 0.84% 25
2025
Q4 		$2.77M Buy
8,460
+125
+1% +$39.7K 0.78% 25
2025
Q3 		$2.35M Sell
8,335
-270
-3% -$78.3K 0.67% 35
2025
Q2 		$2.4M Sell
8,605
-4
-0% -$1.13K 0.7% 31
2025
Q1 		$2.68M Buy
8,609
+170
+2% +$50.2K 0.77% 22
2024
Q4 		$2.2M Buy
8,439
+301
+4% +$89.3K 0.63% 33
2024
Q3 		$2.62M Sell
8,138
-114
-1% -$37.3K 0.68% 31
2024
Q2 		$2.58M Buy
8,252
+56
+0.7% +$16.5K 0.65% 27
2024
Q1 		$2.33M Sell
8,196
-216
-3% -$63.2K 0.64% 32
2023
Q4 		$2.42M Buy
8,412
+87
+1% +$23.7K 0.69% 29
2023
Q3 		$2.24M Buy
+8,325
New +$2.08M 0.66% 28

Other funds holding AMGN

Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
FFM
Forum Financial Management Lombard, Illinois $7.79B AUM 20.38% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
SP
Sarasin & Partners London, United Kingdom $8.54B AUM 9.6% 1-Year Est. Return

Cypress Capital's AMGN Position: Q2 2026 in Review

Cypress Capital reduced its Amgen (AMGN) stake by 3% in Q2 2026, selling an estimated $85.9K and leaving 8,112 shares worth $2.94M. The position accounts for 0.79% of the portfolio, ranked #25.

Cypress Capital first reported a position in AMGN in Q3 2023 and has held it in 12 quarters since. The position peaked at $2.94M in Q1 2026. 1,372 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Cypress Capital held 8,112 shares of Amgen worth $2.94M as of Q2 2026.
  • Cypress Capital sold 251 Amgen shares in Q2 2026, an estimated $85.9K.
  • Amgen made up 0.79% of Cypress Capital's portfolio in Q2 2026, its #25 holding.
  • Cypress Capital first reported a position in Amgen in Q3 2023 and has held it in 12 quarters since.
  • Cypress Capital's Amgen position peaked at $2.94M in Q1 2026.
  • 1,372 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Cypress Capital's 13F filing for Q2 2026, filed 17 Jul 2026.